Erica Lazarus

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Lawrence Corey, Peter B. Gilbert, Michal Juraska et al. · New England Journal of Medicine · 2021 · 492 citations · Full text

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Dan H. Barouch, Frank Tomaka, Frank Wegmann et al. · The Lancet · 2018 · 334 citations · Full text

Vaccination, Vaccine Development, Nhp 13-19 +9

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial

Mark F. Cotton, Avy Violari, Kennedy Otwombe et al. · The Lancet · 2013 · 257 citations

Pediatric Epidemiology, Treatment And Prevention, Hiv Early Antiretroviral +7